Matthias Tacke

Heteroleptic Coumarin-Based Silver(I) Complexes: Possible New Antimicrobial Agents.

Journal: Molecules (Basel, Switzerland)

Published: November 11, 2024

Silver N-heterocyclic carbene complexes are potent uncompetitive inhibitors of the papain-like protease with antiviral activity against SARS-CoV-2.

Journal: RSC medicinal chemistry

Published: February 10, 2023

Pseudomonas aeruginosa and Staphylococcus aureus Display Differential Proteomic Responses to the Silver(I) Compound, SBC3.

Journal: Antibiotics (Basel, Switzerland)

Published: January 05, 2023

The synergistic activity of SBC3 in combination with Ebselen against Escherichia coli infection.

Journal: Frontiers in pharmacology

Published: October 26, 2022

Exposure of Candida parapsilosis to the silver(I) compound SBC3 induces alterations in the proteome and reduced virulence.

Journal: Metallomics : integrated biometal science

Published: January 10, 2022

Continuous flow synthesis and antimicrobial evaluation of NHC* silver carboxylate derivatives of SBC3 in vitro and in vivo.

Journal: Metallomics : integrated biometal science

Published: November 09, 2020

The Antibacterial Drug Candidate SBC3 is a Potent Inhibitor of Bacterial Thioredoxin Reductase.

Journal: Chembiochem : a European journal of chemical biology

Published: October 09, 2020

Novel Anticancer NHC*-Gold(I) Complexes Inspired by Lepidiline A.

Journal: Molecules (Basel, Switzerland)

Published: July 03, 2020

In-vitro and in-vivo investigations into the carbene-gold anticancer drug candidates NHC-Au-SCSNMe2 and NHC-Au-S-GLUC against advanced prostate cancer PC3.

Journal: Anti-cancer drugs

Published: April 14, 2020

Unexpected reactions of NHC*-CuI and -AgI bromides with potassium thio- or seleno-cyanate.

Journal: Acta crystallographica. Section E, Crystallographic communications

Published: August 22, 2019

Synthesis and Cytotoxicity Studies of Novel NHC*-Gold(I) Complexes Derived from Lepidiline A.

Journal: Molecules (Basel, Switzerland)

Published: August 03, 2018

Synthesis and Biological Evaluation of Homogeneous Thiol-Linked NHC*-Au-Albumin and -Trastuzumab Bioconjugates.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany)

Published: February 20, 2018

Heteroleptic Coumarin-Based Silver(I) Complexes: Possible New Antimicrobial Agents.

Heteroleptic Coumarin-Based Silver(I) Complexes: Possible New Antimicrobial Agents.

Silver N-heterocyclic carbene complexes are potent uncompetitive inhibitors of the papain-like protease with antiviral activity against SARS-CoV-2.

Silver N-heterocyclic carbene complexes are potent uncompetitive inhibitors of the papain-like protease with antiviral activity against SARS-CoV-2.

Pseudomonas aeruginosa and Staphylococcus aureus Display Differential Proteomic Responses to the Silver(I) Compound, SBC3.

Pseudomonas aeruginosa and Staphylococcus aureus Display Differential Proteomic Responses to the Silver(I) Compound, SBC3.

The synergistic activity of SBC3 in combination with Ebselen against Escherichia coli infection.

The synergistic activity of SBC3 in combination with Ebselen against Escherichia coli infection.

Exposure of Candida parapsilosis to the silver(I) compound SBC3 induces alterations in the proteome and reduced virulence.

Exposure of Candida parapsilosis to the silver(I) compound SBC3 induces alterations in the proteome and reduced virulence.

Continuous flow synthesis and antimicrobial evaluation of NHC* silver carboxylate derivatives of SBC3 in vitro and in vivo.

Continuous flow synthesis and antimicrobial evaluation of NHC* silver carboxylate derivatives of SBC3 in vitro and in vivo.

The Antibacterial Drug Candidate SBC3 is a Potent Inhibitor of Bacterial Thioredoxin Reductase.

The Antibacterial Drug Candidate SBC3 is a Potent Inhibitor of Bacterial Thioredoxin Reductase.

Novel Anticancer NHC*-Gold(I) Complexes Inspired by Lepidiline A.

Novel Anticancer NHC*-Gold(I) Complexes Inspired by Lepidiline A.

In-vitro and in-vivo investigations into the carbene-gold anticancer drug candidates NHC*-Au-SCSNMe2 and NHC*-Au-S-GLUC against advanced prostate cancer PC3.

In-vitro and in-vivo investigations into the carbene-gold anticancer drug candidates NHC*-Au-SCSNMe2 and NHC*-Au-S-GLUC against advanced prostate cancer PC3.

Unexpected reactions of NHC*-CuI and -AgI bromides with potassium thio- or seleno-cyanate.

Unexpected reactions of NHC*-CuI and -AgI bromides with potassium thio- or seleno-cyanate.

Synthesis and Cytotoxicity Studies of Novel NHC*-Gold(I) Complexes Derived from Lepidiline A.

Synthesis and Cytotoxicity Studies of Novel NHC*-Gold(I) Complexes Derived from Lepidiline A.

Synthesis and Biological Evaluation of Homogeneous Thiol-Linked NHC*-Au-Albumin and -Trastuzumab Bioconjugates.

Synthesis and Biological Evaluation of Homogeneous Thiol-Linked NHC*-Au-Albumin and -Trastuzumab Bioconjugates.

In-vitro and in-vivo investigations into the carbene-gold anticancer drug candidates NHC-Au-SCSNMe2 and NHC-Au-S-GLUC against advanced prostate cancer PC3.

In-vitro and in-vivo investigations into the carbene-gold anticancer drug candidates NHC-Au-SCSNMe2 and NHC-Au-S-GLUC against advanced prostate cancer PC3.